The local medical landscape is buzzing with the emergence of retatrutide, a novel dual GIP and GLP-1 receptor agonist showing impressive results in clinical trials for managing obesity. This treatment https://keiranhrbj827718.alltdesign.com/the-new-retatrutide-australia-a-emerging-hope-for-obesity-treatment-60903552